5.49
0.08 (1.48%)
| Penutupan Terdahulu | 5.41 |
| Buka | 5.31 |
| Jumlah Dagangan | 1,128,767 |
| Purata Dagangan (3B) | 1,266,120 |
| Modal Pasaran | 419,344,288 |
| Harga / Pendapatan (P/E TTM) | 274.50 |
| Harga / Pendapatan (P/E Ke hadapan) | 46.08 |
| Harga / Jualan (P/S) | 5.00 |
| Harga / Buku (P/B) | 13.33 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Mar 2025 - 10 Mar 2025 |
| Margin Keuntungan | 1.62% |
| Margin Operasi (TTM) | 6.26% |
| EPS Cair (TTM) | 0.020 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 31.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 8.42% |
| Nisbah Semasa (MRQ) | 2.95 |
| Aliran Tunai Operasi (OCF TTM) | 4.17 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 4.38 M |
| Pulangan Atas Aset (ROA TTM) | 0.51% |
| Pulangan Atas Ekuiti (ROE TTM) | 4.81% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Packaged Foods (US) | Bercampur | Bercampur |
| Packaged Foods (Global) | Bercampur | Bercampur | |
| Stok | ChromaDex Corporation | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -1.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.40 |
|
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment. |
|
| Sektor | Consumer Defensive |
| Industri | Packaged Foods |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 35.41% |
| % Dimiliki oleh Institusi | 23.92% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 8.00 (Roth MKM, 45.72%) | Beli |
| 8.00 (HC Wainwright & Co., 45.72%) | Beli | |
| Median | 8.00 (45.72%) | |
| Purata | 8.00 (45.72%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 6.37 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Roth MKM | 06 Nov 2024 | 8.00 (45.72%) | Beli | 6.99 |
| HC Wainwright & Co. | 04 Nov 2024 | 8.00 (45.72%) | Beli | 5.74 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| JAKSCH FRANK L JR | - | 6.12 | -37,161 | -227,425 |
| Jumlah Keseluruhan Kuantiti Bersih | -37,161 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -227,425 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 6.12 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| JAKSCH FRANK L JR | Pengarah | 13 Dec 2024 | Jual (-) | 37,161 | 6.12 | 227,425 |
| JAKSCH FRANK L JR | Pengarah | 13 Dec 2024 | Pelaksanaan pilihan | 50,001 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |